Innovent Biologics (HK:1801) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Innovent Biologics has announced the grant of 55,900 share options and 488,200 restricted shares to its non-senior management employees under its 2024 Share Scheme. The options, priced at HK$38.38 per share, will vest over four years contingent upon performance targets. This strategic move aims to incentivize employees while aligning their performance with the company’s objectives.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.